Home » SHIRE SETTLES DRUG LITIGATION WITH BARR
SHIRE SETTLES DRUG LITIGATION WITH BARR
Shire said that it has settled pending litigation over Barr
Pharmaceuticals Inc's generic copy of the extended-release version of Shire's
attention deficit hyperactivity disorder drug Adderall.
Scotsman
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct